Clinical Trial Update: Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing pregabalin to placebo for neuropathic pain in HIV-associated neuropathy; the study was terminated with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathy

Drugs mentioned

• Pregabalin (Pregabalin)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Neuropathy | Phase 3 | Status: TERMINATED | Results posted: 2013-07-17